The company has not filed an annual or quarterly report since its 10-Q, filed Mar 23, 2022. Its latest SEC filing is a 15-12G from Apr 20, 2022.
10-Q, filed Mar 23, 2022
The sections below describe the company as of the FY2021 annual report.
Makes blood-bag temperature indicators, other temperature-monitoring devices and reusable gel packs for hospitals, laboratories and industrial customers.
10-K for FY2021, filed Jul 29, 2021Narrative Description of Business. The Company is presently engaged in the business of developing, manufacturing, and marketing disposable…View ↗
Thermographic and Thermometric Devices and Other Products. During the fiscal year ending April 30, 2021 the Company manufactured and…View ↗
1. The HemoTempR Core Correlated Blood Monitoring Device ("BMD") is designed to be a human blood bag temperature indicator. Human blood…View ↗
8. HemoCoolTM Gel-Pak is a reusable gel pack designed for transporting temperature sensitive materials. The HemoCoolTM Gel-Pak is unique in…View ↗
$1.2M
10-K for FY2021, filed Jul 29, 2021
$1.2M ↗
Hospitals and laboratories are served through distributors and independent sales representatives; the company also markets and sells directly to industrial customers.
10-K for FY2021, filed Jul 29, 2021
10-K for FY2021, filed Jul 29, 2021
Shipments to another customer accounted for 36.7% and 39.5% of sales in fiscal years 2021 and 2020, respectively. As of April 30, 2021 and…View ↗
Yes. It kept 1 cent of every revenue dollar as net income in FY2021.
10-K for FY2021, filed Jul 29, 2021
8-K, filed Jan 21, 2022
On November 24, 2021, Biosynergy, Inc. (“Biosynergy” or the “Company”) filed a Current Report on Form 8-K disclosing that the Company…View ↗
8-K, filed Jan 5, 2022
On December 28, 2021, the Court entered an order finding that Biosynergy has established “dissolution is reasonably necessary because the…View ↗
Shrank.
Revenue fell 5% in 1 year, from $1.2M in FY2020 to $1.2M in FY2021, about 5% a year.
10-K for FY2021, filed Jul 29, 2021
Loading...
